Al-saraireh, Y.M.; Alshammari, F.O.F.O.; Abu-azzam, O.H.; Al-dalain, S.M.; Al-sarayra, Y.M.; Haddad, M.; Makeen, H.; Al-Qtaitat, A.; Almermesh, M.; Al-sarayreh, S.A. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention. Biomedicines2023, 11, 2898.
Al-saraireh, Y.M.; Alshammari, F.O.F.O.; Abu-azzam, O.H.; Al-dalain, S.M.; Al-sarayra, Y.M.; Haddad, M.; Makeen, H.; Al-Qtaitat, A.; Almermesh, M.; Al-sarayreh, S.A. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention. Biomedicines 2023, 11, 2898.
Al-saraireh, Y.M.; Alshammari, F.O.F.O.; Abu-azzam, O.H.; Al-dalain, S.M.; Al-sarayra, Y.M.; Haddad, M.; Makeen, H.; Al-Qtaitat, A.; Almermesh, M.; Al-sarayreh, S.A. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention. Biomedicines2023, 11, 2898.
Al-saraireh, Y.M.; Alshammari, F.O.F.O.; Abu-azzam, O.H.; Al-dalain, S.M.; Al-sarayra, Y.M.; Haddad, M.; Makeen, H.; Al-Qtaitat, A.; Almermesh, M.; Al-sarayreh, S.A. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention. Biomedicines 2023, 11, 2898.
Abstract
Over the past decade, significant developments have occurred in treatment strategies for ovarian cancer, yet targeted therapy with few side effects is still a major issue. The cytochrome P450 (CYP) enzyme family plays a vital role in the tumorigenesis process and metabolism of drugs, with a negative impact on therapy outcomes. Gaining more insight into CYP expression is crucial for understanding the pathophysiology of ovarian cancer since many isoforms are essential for the metabolism of xenobiotics and steroid hormones, which drive the disease's development. The purpose of this review is to provide a clear understanding of differential CYP expression in ovarian cancer and its implications for the prognosis of ovarian cancer patients, together with their polymorphisms' effect on chemotherapy metabolism. Finally, we provide our thoughts on opportunities to exploit metabolic CYP expression for novel therapeutic development to treat ovarian cancer.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.